Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$HALB 0.005 free float 280M
After a lot of failures it seems HALB may be the first to get FDA approval for their cure /medicine to treat PTSD:
https://www.otcmarkets.com/stock/HALB/news/Halberd--Athena-GTX-Report-Initial-Success-of-WatchDawg-PTSD-Treatment-Pilot-Study?id=454495
Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System
Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.
During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.
Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”
Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.
William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”
mdiConsultants guiding the FDA clearance path
LDX will be on the market soon
Another 100 patient test will follow
New PR with test resulta
August 14: number of AUTHORIZED shares raised from 125 million to UNLIMITED
In yesterdays' tweet: IRB established.
The Institutional Review Board reviews and monitors biomedical research involving human subjects (Halberd is conducting clinical trials on Veterans and active duty personel). In accordance with FDA regulations, an IRB has the authority to approve, require modifications (to secure approval), or disapprove research.
Halberd's /Athena's treatment for PTSD is called WatchDawg. Athena coordinates all actions for the military, Halberd the non-military.
the program is being tested right now and is called WatchDawg
Athena also monitors the patient and gives feedback
Athena is adding AI and data collection
LDN+ test results imminent
downgraded to Pink Limited Information
and RNVA is late as well; curious how much they transferred to INQR to work on the Curallo platform
and now they're late filing the annual report!!!
$HALB 0.0084 (NO BRAINER)
News out about CRADA (military contract) to start pilot test for patented LDN+ product, to treat PTSD, depression etc, Multi BILLION market
Also at the moment pilot testing at Mississippi State University on large animals of a (patent pending) nasal spray to treat brain damage. First pilot (on small animals) huge success, most reliable biomarker showed 51% reduction!!!
For both products military contracts expected of $6 million. FDA clinical trials expected to start within 2 months.
https://www.accesswire.com/849919/halberds-patented-drug-ldn-the-subject-of-a-limited-clinical-trial-under-an-innovative-four-company-cooperative-research-and-development-crada-contract
https://www.otcmarkets.com/stock/HALB/news/Halberd-and-Mississippi-State-University-to-Commence-Stage-II-Advanced-TBI-Nasal-Spray-Testing?id=429883
https://www.doi.gov/techtransfer/crada
$HALB 0.0084 (NO BRAINER)
News out about CRADA (military contract) to start pilot test for patented LDN+ product, to treat PTSD, depression etc, Multi BILLION market
Also at the moment pilot testing at Mississippi State University on large animals of a (patent pending) nasal spray to treat brain damage. First pilot (on small animals) huge success, most reliable biomarker showed 51% reduction!!!
For both products military contracts expected of $6 million. FDA clinical trials expected to start within 2 months.
https://www.accesswire.com/849919/halberds-patented-drug-ldn-the-subject-of-a-limited-clinical-trial-under-an-innovative-four-company-cooperative-research-and-development-crada-contract
https://www.otcmarkets.com/stock/HALB/news/Halberd-and-Mississippi-State-University-to-Commence-Stage-II-Advanced-TBI-Nasal-Spray-Testing?id=429883
https://www.doi.gov/techtransfer/crada
What does Athena get in return?
Well, if they're not stupid (they're not) they get at least 50% of all revenue. As you know it is Athena who filed for the two government grants, a total of 6M. They will get it and because of that they guarantee all bills from MSU (nasal spray). Same with LDN+. I did some research and the road to FDA approval for LDN+ is very short. We're waiting for news about both. So far investing in $HALB has turned out very profitable. I took some profits when they "peaked", but now have more than ever, buying the dips.
waiting for news about the 2 gov. contracts
working on the nasal spray to treat brain damage en LDN+
partnered with Athena who pays the R&D bills
Hi Squid, nice to see you're back....
WEST PALM BEACH, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR) announces that, to date, certain common shareholders have agreed to exchange a total of 40,700,000 common shares for shares of Series E and F Preferred Stock at an exchange value of $0.005 per share of common stock. Each shareholder will receive 50% of the value of common shares exchanged in Series E Preferred Stock and the remaining 50% in Series F Preferred Stock. This reduces the currently issued number of common shares from 244,953,286 to 204,253,286.
https://www.otcmarkets.com/stock/INQR/news/story?e&id=2772886
funding is being spend on building Curallo
but RNVA is still funding Innovaqor
no follow up to the 8-K about RS
very quiet lately
$HALB OS 635M SP 0.009
Something happening (finally):
- signed a funding/revenue sharing agreement with Athena GTX
- together working on 2 military contracts for $6M
- Athena GTX gets more than 50% of its revenue from government contracts
- together developing treatments against PTSD, TBI, pain&anxiety
Today HALB announced a second phase in animal testing at Mississippi State University
https://www.otcmarkets.com/stock/HALB/news/Halberd-and-Mississippi-State-University-to-Commence-Stage-II-Advanced-TBI-Nasal-Spray-Testing?id=429883
$HALB OS 635M SP 0.009
Something happening (finally):
- signed a funding/revenue sharing agreement with Athena GTX
- together working on 2 military contracts for $6M
- Athena GTX gets more than 50% of its revenue from government contracts
- together developing treatments against PTSD, TBI, pain&anxiety
Today HALB announced a second phase in animal testing at Mississippi State University
https://www.otcmarkets.com/stock/HALB/news/Halberd-and-Mississippi-State-University-to-Commence-Stage-II-Advanced-TBI-Nasal-Spray-Testing?id=429883
CHECK Twitter:
Halberd Corporation
@HalberdC
Stay tuned for two significant announcements from $HALB early this week!
1:44 PM · Jan 8, 2024
·
224 Views
You have to go back to May '23 interview to know what's coming. Everybody thought it was more bluff, but seems he nailed it. If so: boom!
I have a very good feeling going into 2024. It has been quiet for a long time, dealing with potential partners, but I’m sure Halberd will rock.
talks with AthenaGTX take longer than expected
quarterly report, nothing new, no subsequent events
company still OTC Current information
financial report filed
CURALLO is on youtube. Also a short version on the Innovaqor/curallo website. You have to register first to view the full version. IT LOOKS GREAT!
$INQR Innovaqor Inc SP 0.0037 Float 158M MC 900K
INQR is developing a Communication Platform for Healthcare Professionals:
- the communication network is called CURALLO
- fully funded ($1 million in 2023, $2.5 million last 2 years) by former parent company
- company has audited fins and is fully SEC reporting
- part of the platform is a Recruitment platform for employers (hospitals, clinics etc), think LinkedIn
- revenue from subscription fees, talent search etc.
This stock will explode soon. I expect updates about partners and multi-million dollar funding. Take a first look:
insert-text-here
https://www.otcmarkets.com/stock/INQR/security
$INQR Innovaqor Inc SP 0.0037 Float 158M MC 900K
INQR is developing a Communication Platform for Healthcare Professionals:
- the communication network is called CURALLO
- fully funded ($1 million in 2023, $2.5 million last 2 years) by former parent company
- company has audited fins and is fully SEC reporting
- part of the platform is a Recruitment platform for employers (hospitals, clinics etc), think LinkedIn
- revenue from subscription fees, talent search etc.
This stock will explode soon. I expect updates about partners and multi-million dollar funding. Take a first look:
insert-text-here
https://www.otcmarkets.com/stock/INQR/security